Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Operating Expenses | 32,918 | 24,067 | 0 | 0 | 0 |
| Operating Income | -32,918 | -24,067 | N/A | N/A | N/A |
| Other Income | -29 | 100 | 0 | 0 | 0 |
| Pre-tax Income | -32,947 | -23,967 | 0 | 0 | 0 |
| Net Income Continuous | -32,947 | -23,967 | N/A | N/A | N/A |
| Net Income | $-32,947 | $-23,967 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -11.33 | -36.27 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -11.33 | -36.26 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -11.33 | -36.27 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -11.33 | -36.26 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -11.33 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-32,250 | $-23,448 | $N/A | $N/A | $N/A |